Common disease-promoting signalling pathways in heart failure and atrial fibrillation: putative underlying mechanisms and potential therapeutic consequences

Cardiovasc Res. 2022 Aug 24;118(11):2397-2399. doi: 10.1093/cvr/cvac107.

Joshua A Keefe^{1

2}, Xander H T Wehrens^{1

2

3

4

5}, Dobromir Dobrev^{2

6

7}

¹ Cardiovascular Research Institute, Baylor College of Medicine, Houston, TX 77030, USA.
² Departments of Integrative Physiology, Baylor College of Medicine, Houston, TX 77030, USA.
³ Medicine (Cardiology), Baylor College of Medicine, Houston, TX 77030, USA.
⁴ Pediatrics (Cardiology), Baylor College of Medicine, Houston, TX 77030, USA.
⁵ Center for Space Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
⁶ Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, 45147 Essen, Germany.
⁷ Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, Montréal, QC H1T 1C8, Canada.

No abstract available

Publication types